SCHEMBL13728016

SCHEMBL13728016

Nc1ccccc1NCCC(=O)O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.64
HPGD P15428 2/20 0.64
HSD17B10 Q99714 2/20 0.64
MEN1 O00255 1/20 0.54
NSD2 O96028 1/20 0.54
POLB P06746 1/20 0.54
BLM P54132 1/20 0.54
KMT2A Q03164 1/20 0.54
RXFP1 Q9HBX9 1/20 0.54
KDM4E B2RXH2 1/20 0.53
MAPT P10636 1/20 0.53
AKR1C3 P42330 1/20 0.53
AKR1C2 P52895 1/20 0.53
AKR1C1 Q04828 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
HDAC1 Q13547 11/20 0.50
HDAC3 O15379 10/20 0.50
HDAC2 Q92769 10/20 0.50
NCOR2 Q9Y618 6/20 0.50
HDAC10 Q969S8 5/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3871501 0.89 HDAC1 (0.55) ALDH1A1HPGDHSD17B10KDM4EHDAC1
SCHEMBL863993 0.86 HDAC1 (0.63) ALDH1A1HPGDHSD17B10HDAC1HDAC3
SCHEMBL11061872 0.86 HDAC1 (0.63) ALDH1A1HPGDHSD17B10HDAC1HDAC3
SCHEMBL7373085 0.85 SHMT2 (0.49) ALDH1A1HPGDHSD17B10KMT2AL3MBTL1
Hydrochloric Acid SCHEMBL29008104 0.81 HDAC1 (0.52) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL1697077 0.81 HDAC1 (0.52) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL10875175 0.81 ALDH1A1 (0.50) ALDH1A1HPGDHSD17B10POLBKDM4E
SCHEMBL2973683 0.80 HDAC3 (0.47) ALDH1A1HPGDHSD17B10MEN1KMT2A
SCHEMBL29939818 0.80 HDAC3 (0.45) ALDH1A1HPGDHSD17B10HDAC1HDAC3
SCHEMBL6201094 0.80 MAPT (0.52) ALDH1A1HPGDHSD17B10MEN1BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1172929-C substituted indoles ���ĵ�˹ҩ��¹����޹�˾ 2004-10-27 CN claimed
CN-1168727-C Substituted benzimidazole ���ĵ�˹ҩ��¹����޹�˾ 2004-09-29 CN claimed
WO-2020044206-A1 HETEROCYCLIC AMIDES AS KINASE INHIBITORS FOR USE IN THE TREATMENT CANCER GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2020-03-05 WO disclosed
EP-2705039-A2 BROMODOMAIN INHIBITORS AND USES THEREOF Constellation Pharmaceuticals, Inc. (US) 2014-03-12 EP disclosed
WO-2012151512-A2 BROMODOMAIN INHIBITORS AND USES THEREOF CONSTELLATION PHARMACEUTICALS, INC. (US) 2012-11-08 WO disclosed
CN-1172929-C substituted indoles ���ĵ�˹ҩ��¹����޹�˾ 2004-10-27 CN disclosed
CN-1168727-C Substituted benzimidazole ���ĵ�˹ҩ��¹����޹�˾ 2004-09-29 CN disclosed
CN-1379772-A Substituted indoles for modulating NF kappa B activity AVENTIS PHARMA GMBH (DE) 2002-11-13 CN disclosed
CN-1356995-A Substituted benzimidazole AVENTIS PHARMA GMBH (DE) 2002-07-03 CN disclosed